- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 357
Ovid to go over to public markets
Sanofi and Takeda-backed Ovid Therapeutics has filed to raise $86.3m in an initial public offering and plans to use the proceeds to advance its neurological disease treatments.
Apr 13, 2017ReNew Power targets $600m in IPO charge
The wind and solar power producer has raised more than $850m in total equity funding, including $200m from Tokyo Electric Power and Chubu Electric Power this year.
Apr 10, 2017Big Deal: Sina exits Toutiao in $1bn round
The social media company has scored a huge exit from news app Toutiao, exiting as part of a series D round that valued it at $11bn, 22 times the valuation at which Sina invested in 2014.
Apr 10, 2017Allied Minds cuts off funds to seven spinouts
Tinnitus Treatment Solutions and food standards and sanitation company RF Biocidics are among the casualties of the $146.6m writedown, with capital being diverted to more promising subsidiaries.
Apr 7, 2017Square enters talks for Yik Yak acquisition
The Renren-backed social media platform, once valued at up to $400m, is in talks with Square for an acqui-hire deal.
Apr 7, 2017Spotify scutinises public listing options
The corporate-backed music platform is reportedly mulling a public market listing that would not raise money but which would allow investors to divest their shares.
Apr 7, 2017PetCoach gets a new owner
Petco has purchased petcare services platform PetCoach for an undisclosed sum, providing an exit to corporate investors Comcast and Pet360.
Apr 5, 2017Grab pays up to $100m for Kudo
Grab has completed the acquisition of Emtek, Gree and Singapore Press Holdings-backed mobile payment portal Kudo for between $80m and $100m.
Apr 5, 2017Cohesity stores away $90m
GV has led a series C round that valued the secondary storage technology provider at more than $500m with backing from Cisco, Qualcomm and Hewlett Packard Enterprise.
Apr 5, 2017Zymeworks looks to construct $75m IPO
Eli Lilly is the oncology antibody developer's largest shareholder, while other investors include Celgene and EMS subsidiary Brace Pharma Capital.
Apr 5, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


